用于向癌症治疗的抗体-药物联合体:潜在有效载荷的最新进展
Meiyang Xi1, Jingjing Zhu2, Fengxia Zhang2
1Zhejiang Engineering Research Center of Fat-soluble Vitamin, Shaoxing University, Shaoxing, 312000, China; College of Chemistry and Chemical Engineering, Shaoxing University, Shaoxing, 312000, China.
European journal of medicinal chemistry
|July 28, 2024
概括
抗体-药物联合体 (ADC) 通过提供强大的有效载荷,提供向癌症治疗. 在有效载荷设计方面的创新,包括免疫调节剂和PROTACs,旨在克服毒性和耐药性等挑战,以改善癌症治疗.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗体-药物合物 (ADC) 是一种新兴的癌症疗法,利用单克隆抗体 (mAbs) 专门向癌细胞输送细胞毒性有效载荷.
- 有15种ADC获得批准,有100多种在临床试验中,突出了它们在治疗各种癌症方面的重要性.
- 目前的ADC有效载荷主要包括微管向和DNA损伤剂,但由于毒性和耐药性而面临限制.
研究的目的:
- 审查抗体与药物联合体 (ADC) 的作用机制.
- 强调有效载荷在ADC有效性中的关键作用.
- 总结传统和新型ADC有效载荷的进展,探索克服治疗挑战的策略.
主要方法:
- 对抗体-药物结合机制和有效载荷发展的文献综述.
- 分析目前的ADC批准和临床试验进展情况.
- 综合有关常规和创新的有效载荷类型的信息,包括免疫调节剂和向蛋白质溶解的嵌合体 (PROTACs).
主要成果:
- 抗癌药物展示了针对癌症治疗的有针对性的方法,通过mAbs.提供强大的毒素.
- 有效载荷的多样化对于提高ADC的有效性和解决阻力机制至关重要.
- 像免疫调节剂和PROTACs这样的创新有效载荷正在被整合起来,以实现多式模式的癌症治疗策略.
结论:
- 有效载荷的选择和多样化是ADC成功的关键决定因素.
- 克服ADC的局限性需要探索超越传统细胞毒剂的新型有效载荷.
- 未来的ADC开发取决于创新的有效载荷策略,以扩大治疗应用并改善患者的治疗结果.
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:27Tumor Immunotherapy
498
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
498
01:30Cancer Vaccines
347
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
347